Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV
NCT01637844
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
335
Enrollment
OTHER
Sponsor class
Conditions
HBV
Interventions
DRUG:
Telbivudine
Sponsor
Yi-Hua Zhou
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]